Sun Pharmaceutical Industries Limited’s revenue in Q3FY23 rose 14% to ₹ 112,410 millions. Consolidated Profit After Tax came at ₹ 21,808 millions
Categories
Health Care
SUVEN PHARMACEUTICALS LTD (SUVEN) Q3 FY23 Earnings Concall Transcript
SUVEN PHARMACEUTICALS LTD (NSE:SUVEN) Q3 FY23 Earnings Concall dated Feb. 07, 2023. Corporate Participants: Rishab Barar -- Investor Relations Venkat Jasti -- Managing Director Venkatraman Sunder -- Vice
Aarti Industries Ltd Q3 FY23 Earnings Conference Call Insights
Key highlights from Aarti Industries Ltd (AARTIIND) Q3 FY23 Earnings Concall Management Update: [00:04:16] AARTIIND said demand for textile products was impacted
Gujarat Themis Biosyn Limited (506879) Q3 FY23 Earnings Concall Transcript
Gujarat Themis Biosyn Limited (NSE:506879) Q3 FY23 Earnings Concall dated Feb. 06, 2023. Corporate Participants: Sachin Patel -- Director Rajneesh Anand -- Consultant Analysts: Saloni Hemnani -- Molecule
MedPlus Health Services Ltd (MEDPLUS) Q3 FY23 Earnings Concall Transcript
MedPlus Health Services Ltd (NSE:MEDPLUS) Q3 FY23 Earnings Concall dated Feb. 06, 2023. Corporate Participants: Prasad Reddy Battinapatla -- Assistant Financial Controller Gangadi Madhukar
Poly Medicure Limited (POLYMED) Q3 FY23 Earnings Concall Transcript
Poly Medicure Limited (NSE:POLYMED) Q3 FY23 Earnings Concall dated Feb. 06, 2023. Corporate Participants: Himanshu Baid -- Managing Director Analysts: Rohan John -- ICICI Securities --
AMI Organics Ltd (AMIORG) Q3 FY23 Earnings Concall Transcript
AMI Organics Ltd (NSE: AMIORG) Q3 FY23 Earnings Concall dated Feb. 04, 2023 Corporate Participants: Bhavin Shah -- Chief Financial Officer Nareshkumar Patel -- Chief Executive
Aarti Industries Ltd (AARTIIND) Q3 FY23 Earnings Concall Transcript
Aarti Industries Ltd (NSE: AARTIIND) Q3 FY23 Earnings Concall dated Feb. 06, 2023 Corporate Participants: Nishid Solanki -- Investor Relations Rajendra Gogri -- Chairman and Managing
Thyrocare Technologies Ltd (THYROCARE) Q3 FY23 Earnings Concall Transcript
Thyrocare Technologies Ltd (NSE:THYROCARE) Q3 FY23 Earnings Concall dated Feb. 03, 2023. Corporate Participants: Rahul Guha -- Managing Director and Chief Executive Officer Sachin
Zydus Lifesciences Ltd (ZYDUSLIFE) Q3 FY23 Earnings Concall Transcript
Zydus Lifesciences Ltd (NSE:ZYDUSLIFE) Q3 FY23 Earnings Concall dated Feb. 03, 2023. Corporate Participants: Ganesh N. Nayak -- Executive Director Sharvil P. Patel -- Managing Director
Emami Limited (EMAMILTD) Q3 FY23 Earnings Concall Transcript
Emami Limited (NSE:EMAMILTD) Q3 FY23 Earnings Concall dated Feb. 03, 2023. Corporate Participants: Mohan Goenka -- Vice Chairman & Whole-Time Director Gul Raj Bhatia -- President,
Jubilant Pharmova Limited (JUBLPHARMA ) Q3 FY23 Earnings Concall Transcript
Jubilant Pharmova Limited (NSE:JUBLPHARMA) Q3 FY23 Earnings Concall dated Feb. 03, 2023. Corporate Participants: Vineet Mayer -- Investor Relations and Corporate Finance Shyam S
GMM Pfaudler Limited (GMMPFAUDLR) Q3 FY23 Earnings Concall Transcript
GMM Pfaudler Limited (NSE:GMMPFAUDLR) Q3 FY23 Earnings Concall dated Feb. 03, 2023. Corporate Participants: Priyanka Daga -- Deputy General Manager Tarak Patel -- Managing Director Manish
Mahindra Lifespace Developers Limited (MAHLIFE) Q3 FY23 Earnings Concall Transcript
Mahindra Lifespace Developers Limited (NSE:MAHLIFE) Q3 FY23 Earnings Concall dated Feb. 03, 2023. Corporate Participants: Arvind Subramanian -- Managing Director and Chief Executive Officer
Max Healthcare Institute Ltd (MAXHEALTH) Q3 FY23 Earnings Concall Transcript
Max Healthcare Institute Ltd (NSE:MAXHEALTH) Q3 FY23 Earnings Concall dated Feb. 03, 2023. Corporate Participants: Anoop Poojari -- Client Manager - Citigate Dewe
Divi’s Laboratories Ltd (DIVISLAB) Q3 FY23 Earnings Concall Transcript
Divi's Laboratories Ltd (NSE: DIVISLAB) Q3 FY23 Earnings Concall dated Feb. 03, 2023 Corporate Participants: M. Satish Choudhury -- Company Secretary and Chief Investor
Dr Lal PathLabs Ltd Q3 FY23 Earnings Conference Call Insights
Key highlights from Dr Lal PathLabs Ltd (LALPATHLAB) Q3 FY23 Earnings Concall Q&A Highlights: [00:12:28] Dheeresh Pathak from WhiteOak asked about the
Zydus Lifesciences Q3FY23 net profit rises by 23%; Revenue soars 20%
Zydus Lifesciences Ltd reported a 23 per cent rise in consolidated net profit at INR 631 crore for the third quarter ended
Max Healthcare Q3FY23; 7% Growth in Profits
Max Healthcare Institute Ltd.’s gross revenue in Q3FY23 rose 13% to ₹ 1,559 crores. Consolidated Profit After Tax came at ₹ 269
Alembic Pharmaceuticals Limited (APLLTD) Q3 FY23 Earnings Concall Transcript
Alembic Pharmaceuticals Limited (NSE:APLLTD) Q3 FY23 Earnings Concall dated Feb. 01, 2023. Corporate Participants: R.K. Baheti -- Director, Finance and Chief Financial Officer Shaunak
Hester Biosciences Limited (HESTERBIO) Q3 FY23 Earnings Concall Transcript
Hester Biosciences Limited (NSE:HESTERBIO) Q3 FY23 Earnings Concall dated Jan. 31, 2023. Corporate Participants: Rajiv Gandhi -- Chief Executive Officer and Managing Director Priya